Qube Research & Technologies (QRT)
LFCR icon

Qube Research & Technologies (QRT)’s Lifecore Biomedical LFCR Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-75,097
Closed -$279K – 3816
2026
Q1 		$279K Buy
+75,097
New +$519K ﹤0.01% 2883
2025
Q4 		– Sell
-14,133
Closed -$104K – 3901
2025
Q3 		$104K Sell
14,133
-3,533
-20% -$26.7K ﹤0.01% 3056
2025
Q2 		$143K Sell
17,666
-37,741
-68% -$254K ﹤0.01% 2975
2025
Q1 		$390K Sell
55,407
-19,325
-26% -$120K ﹤0.01% 2638
2024
Q4 		$555K Sell
74,732
-19,644
-21% -$125K ﹤0.01% 2421
2024
Q3 		$465K Buy
94,376
+12,904
+16% +$67.4K ﹤0.01% 2297
2024
Q2 		$418K Sell
81,472
-61,807
-43% -$366K ﹤0.01% 2204
2024
Q1 		$761K Sell
143,279
-4,147
-3% -$29.7K ﹤0.01% 2305
2023
Q4 		$913K Buy
147,426
+120,095
+439% +$834K ﹤0.01% 1976
2023
Q3 		$206K Sell
27,331
-580
-2% -$5.3K ﹤0.01% 2396
2023
Q2 		$270K Buy
+27,911
New +$170K ﹤0.01% 1686

Other funds holding LFCR

WC
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

Qube Research & Technologies (QRT)'s LFCR Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of Lifecore Biomedical (LFCR) in Q2 2026, closing a stake of 75,097 shares — an estimated $279K sold.

Qube Research & Technologies (QRT) first reported a position in LFCR in Q2 2023 and held it in 11 quarters. The position peaked at $913K in Q4 2023. 98 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining Lifecore Biomedical position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 75,097 Lifecore Biomedical shares in Q2 2026, an estimated $279K.
  • Qube Research & Technologies (QRT) first reported a position in Lifecore Biomedical in Q2 2023 and held it in 11 quarters.
  • Qube Research & Technologies (QRT)'s Lifecore Biomedical position peaked at $913K in Q4 2023.
  • 98 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.